26 - 27 November, 2019 | Millennium Gloucester Hotel London Kensington, London, United Kingdom

Day Two

8:30 - 8:55 Registration and Welcome Coffee

Dr Sven Bostyn Lic.Jur., LLM, PhD, Associate Professor of Biomedical Innovation Law at Law Center for Advanced studies in Biomedical Innovation Law

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law

9:00 - 9:35 Patent Infringement and Second Medical Use Claims: A Problem That Is Not a Problem?

Courts across Europe have struggled with the question of patent infringement of second medical use claims. A solution is in fact not that difficult and is at hand, but it will require involvement of the legislator. Dr. Sven Bostyn will address this issue, exploring:
·         Second medical use claims and patent infringement
·         Legal uncertainty across Europe
·         How this effects both innovators and generic companies
·         A solution that will remove the majority of the uncertainty
Dr Sven Bostyn Lic.Jur., LLM, PhD, Associate Professor of Biomedical Innovation Law at Law Center for Advanced studies in Biomedical Innovation Law

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law

9:35 - 10:10 Patent Enforcement Strength in 52 Countries Worldwide:Implications for Your Patent Filing Litigation Strategies

The strength and effectiveness of patent enforcement in a country is one of the aspects considered when developing your patent filing and litigation strategies. Nikolaos will be discuss:
·         The latest assessment of the levels of patent enforcement strength in 52 countries worldwide
·         Identifying countries where you should anticipate that the enforcement of your patents is likely to be problematic.
·         Understanding which countries could be earmarked or dropped out of patent filing and renewing decisions, from the perspective of patent enforcement strength.
·         If you should be enforcing your patents in China?
Nikolaos Papageorgiadis, Senior Lecturer at University of Liverpool

Nikolaos Papageorgiadis

Senior Lecturer
University of Liverpool

10:10 - 10:45 When All Comes Together: Change the way of Searching Prior-Art in Life Science

Orbit BioSequence is the only software platform that allows IPR professionals to do sequence searching in a fully featured patent platform. It is entirely made for IP searchers and allows you to see sequence alignments in a patent and family context.
 
Denis Bayada of Questel and the creator of Orbit BioSequence will discuss how his solution can combine and analyse:
·         Sequence searches
·         Small molecule searches
·         Text, concepts and legal status searches
Denis Bayada, Product Manager Orbit at Questel

Denis Bayada

Product Manager Orbit
Questel

Fabienne Persijn, Key Account Executive at Questel

Fabienne Persijn

Key Account Executive
Questel

10:45 - 11:15 Morning Break and Networking

11:15 - 11:50 What the New SPC Waiver Regulation (EU) 2019/933 Means for the Life Science Industry


Jane Lambert QC, Barrister at 4-5 Gray's Inn Square

Jane Lambert QC

Barrister
4-5 Gray's Inn Square

11:50 - 12:25 Lessons Learned from a Funder of IP Litigation

Harbour Litigation’s funds (which now amount to £750 million) have financed over 150 claims globally. They are the experts in funding IP cases.  In this presentation, Susan Dunn, Founder of Harbour will discuss:
·         How to get a case funded and typical terms for funded parties
·         How to value your claim
·         Specific issues when litigating in the UK, Germany and the US
Susan Dunn, CEO at Harbour Litigation Fund

Susan Dunn

CEO
Harbour Litigation Fund

13:00 - 14:00 Networking Lunch

14:00 - 14:40 Interactive Discussion Groups


·         ALTERNATIVE DISPUTE RESOLUTIONS
·         FINDING IP AGREEMENT IN COLLABORATION BETWEEN ACADEMICS AND BUSINESS DURING R&D
·         GETTING SCIENTISTS ON YOUR SIDE
·         WORLDWIDE LAWMAKERS AREN’T KEEPING UP WITH THE RATE OF LIFE SCIENCE R&D – WHAT CAN WE DO?
·         COLLABORATION OF INHOUSE COUNSEL AND EXTERNAL FIRMS FOR EFFECTIVE IP STRATEGY
This panel will address the challenges of developing a patent portfolio in an era of lengthier product development timelines, more stringent patent office processes and increasing competition. Our panel will discuss:
·         Real-world examples of creative patent commercialisation
·         Outside of the box ideas and theories for commercialisation strategies
·         What is and is not feasible in the commercial realm
Harriet Strimpel, Chief IP Counsel at New England Biolabs

Harriet Strimpel

Chief IP Counsel
New England Biolabs

Professor Mark Engelman QC, Head of Intellectual Property, Barrister at Hardwicke Chambers

Professor Mark Engelman QC

Head of Intellectual Property, Barrister
Hardwicke Chambers

Sally Bannan, Senior European Patent Attorney at GE

Sally Bannan

Senior European Patent Attorney
GE

To conclude our event, our chairperson will be hosting a wind-down session to reflect on the insights gleaned throughout the course of the previous two days.
 
Dr Sven Bostyn Lic.Jur., LLM, PhD, Associate Professor of Biomedical Innovation Law at Law Center for Advanced studies in Biomedical Innovation Law

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law

15:30 - 15:45 SUMMARY SESSION - QUIZ!

End your conference with a good old fashioned pub quiz!
 
Designed to test what you’ve learned at the conference, each participant is given an answer sheet and will be asked a series of LSIP related questions. Keep your sheets as a reference guide to take back to the office with you!